Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults
- PMID: 22405043
- PMCID: PMC3398228
- DOI: 10.1016/j.neurobiolaging.2012.01.014
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults
Abstract
The apolipoprotein E (APOE) ε4 allele increases the risk for late-onset Alzheimer's disease (AD) and age-related cognitive decline. We investigated whether ε4 carriers show reductions in gray matter volume compared with ε4 non-carriers decades before the potential onset of AD dementia or healthy cognitive aging. Fourteen cognitively normal ε4 carriers, aged 26 to 45 years, were compared with 10 age-matched, ε4 non-carriers using T1-weighted volumetric magnetic resonance imaging (MRI) scans. All had reported first- or second-degree family histories of dementia. Group differences in gray matter were tested using voxel-based morphometry (VBM) and a multivariate model of regional covariance, the Scaled Subprofile Model (SSM). A combination of the first two SSM MRI gray matter patterns distinguished the APOE ε4 carriers from non-carriers. This combined pattern showed gray matter reductions in bilateral dorsolateral and medial frontal, anterior cingulate, parietal, and lateral temporal cortices with covarying relative increases in cerebellum, occipital, fusiform, and hippocampal regions. With these gray matter differences occurring decades before the potential onset of dementia or cognitive aging, the results suggest longstanding, gene-associated differences in brain morphology that may lead to preferential vulnerability for the later effects of late-onset AD or healthy brain aging.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Alexander GE, Chen K, Merkley TL, Reiman EM, Caselli RJ, Aschenbrenner M, Lewis DJ, Pietrini P, Teipel SJ, Hampel H, Rapoport SI, Moeller JR. Regional network of magnetic resonance imaging gray matter volume in healthy aging. NeuroReport. 2006;17:951–56. - PubMed
-
- Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry. 2002;159:738–55. - PubMed
-
- Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry. 1997;154:165–172. - PubMed
-
- Alexander GE, Mentis MJ, Van Horn JD, Grady CL, Berman KF, Furey ML, Pietrini P, Schapiro MB, Rapoport SI, Moeller JR. Individual differences in PET activation of object perception and attention systems predict face matching accuracy. NeuroReport. 1999;10:1965–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
